Literature DB >> 4195059

Parathyroid hormone and experimental osteosclerosis.

D N Kalu, F H Doyle, J Pennock, G V Foster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4195059     DOI： 10.1016/s0140-6736(70)91271-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Recombinant human parathyroid hormone.

Authors:  Jonathan Reeve
Journal:  BMJ       Date:  2002-02-23

2.  Recessive hypophosphataemic rickets, and possible aetiology of the 'vitamin D-resistant' syndrome.

Authors:  T C Stamp; L R Baker
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

3.  Generalized osteosclerosis in primary hyperparathyroidism.

Authors:  T B Connor; J Freijanes; R E Stoner; L G Martin; J Jowsey
Journal:  Trans Am Clin Climatol Assoc       Date:  1974

Review 4.  The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.

Authors:  C R Kleeman; S G Massry; J W Coburn
Journal:  Calif Med       Date:  1971-04

5.  Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats.

Authors:  J Wergedal; M Stauffer; D Baylink; C Rich
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

6.  Influence of an orally administered calcium-binding cation exchanger on calcium metabolism in the rat.

Authors:  V Hagmaier; B Flückiger; A Scholer; W Remagen; G Rutishauser
Journal:  Urol Res       Date:  1979-12

7.  A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the rat.

Authors:  T Takano-Yamamoto; G A Rodan
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

8.  Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

Authors:  M Neer; D M Slovik; M Daly; T Potts; S R Nussbaum
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

9.  Plasma calcitonin in renal osteodystrophy.

Authors:  S M Chittal; D G Oreopoulos; G A DeVeber; P Thomas; S Rabinovich; G J Lloyd; M A Kumar; A Rapoport
Journal:  Can Med Assoc J       Date:  1971-06-19       Impact factor: 8.262

10.  Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction.

Authors:  M M Walka; S Däumling; H B Hadorn; K Kruse; B H Belohradsky
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.